EP0671954A4 - - Google Patents

Info

Publication number
EP0671954A4
EP0671954A4 EP93904949A EP93904949A EP0671954A4 EP 0671954 A4 EP0671954 A4 EP 0671954A4 EP 93904949 A EP93904949 A EP 93904949A EP 93904949 A EP93904949 A EP 93904949A EP 0671954 A4 EP0671954 A4 EP 0671954A4
Authority
EP
European Patent Office
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP93904949A
Other versions
EP0671954A1 (en
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of EP0671954A1 publication Critical patent/EP0671954A1/en
Publication of EP0671954A4 publication Critical patent/EP0671954A4/xx
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP93904949A 1992-02-05 1993-02-05 Interferon gene therapy for the treatment of vascular disorders Withdrawn EP0671954A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US83145392A 1992-02-05 1992-02-05
PCT/US1993/001072 WO1993015609A1 (en) 1992-02-05 1993-02-05 Interferon gene therapy for the treatment of vascular disorders
US831453 1997-03-31

Publications (2)

Publication Number Publication Date
EP0671954A1 EP0671954A1 (en) 1995-09-20
EP0671954A4 true EP0671954A4 (cs) 1995-10-11

Family

ID=25259093

Family Applications (1)

Application Number Title Priority Date Filing Date
EP93904949A Withdrawn EP0671954A1 (en) 1992-02-05 1993-02-05 Interferon gene therapy for the treatment of vascular disorders

Country Status (3)

Country Link
EP (1) EP0671954A1 (cs)
CA (1) CA2131550A1 (cs)
WO (1) WO1993015609A1 (cs)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5545723A (en) * 1994-03-15 1996-08-13 Biogen Inc. Muteins of IFN-β
AU2195095A (en) * 1994-03-24 1995-10-09 University Of Washington Devices and methods for implanting transduced cells
AU728146B2 (en) 1996-03-14 2001-01-04 Immune Response Corporation, The Targeted delivery of genes encoding interferon
US6140305A (en) 1996-04-04 2000-10-31 Bio-Rad Laboratories, Inc. Hereditary hemochromatosis gene products
US7026116B1 (en) 1996-04-04 2006-04-11 Bio-Rad Laboratories, Inc. Polymorphisms in the region of the human hemochromatosis gene
US6849399B1 (en) 1996-05-23 2005-02-01 Bio-Rad Laboratories, Inc. Methods and compositions for diagnosis and treatment of iron misregulation diseases
EP2356998A1 (en) 2010-02-17 2011-08-17 Université de Liège A pharmaceutical composition for treatment of thrombosis-related diseases comprising a fragment of prolactin (PRL)-growth hormone (GH) - placental lactogen (PL)-family protein
CN102892778B (zh) 2010-02-19 2018-06-08 列日大学 用于治疗甲型流感病毒诱发的疾病、编码经修饰的Mx蛋白的多核苷酸、蛋白和转基因动物
WO2012013249A1 (en) 2010-07-30 2012-02-02 Université de Liège Dentin matrix protein 1 (dmp1) for use in pharmaceutical compositions

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990003189A1 (en) * 1988-09-30 1990-04-05 Hansson Goeran Use of gamma-interferon for the treatment of vascular stenosis
WO1990011734A1 (en) * 1989-03-31 1990-10-18 The Regents Of The University Of Michigan Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3273597D1 (en) * 1981-11-28 1986-11-06 Sunstar Kk Pharmaceutical composition containing interferon in stable state

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990003189A1 (en) * 1988-09-30 1990-04-05 Hansson Goeran Use of gamma-interferon for the treatment of vascular stenosis
WO1990011734A1 (en) * 1989-03-31 1990-10-18 The Regents Of The University Of Michigan Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
GÖRAN K. HANSSON ET AL: "Interferon-gamma inhibits arterial stenosis after injury", CIRCULATION, vol. 84, no. 3, September 1991 (1991-09-01), pages 1266 - 1272 *
HIROMI OGURA ET AL: "Implantation of genetically manipulated fibroblasts into mice antitumor alpha-interferon therapy", CANCER, vol. 50, no. 16, 15 August 1990 (1990-08-15), RESEARCH, pages 5102 - 5106, XP000906780 *
See also references of WO9315609A1 *

Also Published As

Publication number Publication date
WO1993015609A1 (en) 1993-08-19
EP0671954A1 (en) 1995-09-20
CA2131550A1 (en) 1993-08-19

Similar Documents

Publication Publication Date Title
BR9304651A (cs)
DK0574087T3 (cs)
TW270086B (cs)
BR9207065A (cs)
DK0574276T3 (cs)
BR9202713C1 (cs)
DE9209779U1 (cs)
AU632452B2 (cs)
BRPI9204323A2 (cs)
AU2098792A (cs)
AU1809592A (cs)
AU633800B1 (cs)
EP0671954A4 (cs)
AU1812892A (cs)
AU1842892A (cs)
AU1861992A (cs)
AU1862992A (cs)
AU1935292A (cs)
AU2053892A (cs)
AU1610792A (cs)
AU2130892A (cs)
AU2202592A (cs)
AU2281492A (cs)
AU2286392A (cs)
AU2527592A (cs)

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19940905

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 19950828

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Withdrawal date: 19960524